Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Merck's new fibrinogen receptor antagonists

Oct. 9, 1997

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Oct. 6, 1997

Neutralase proceeds to phase III trials

Oct. 3, 1997

Cor Therapeutics submits NDA amendment for Integrilin to FDA

Oct. 2, 1997

Clinical results presented for Knoll's PEG-hirudin

Sep. 30, 1997

SKB reports new antiplatelet agents

Sep. 29, 1997

Astra describes prodrugs of thrombin inhibitors

Sep. 26, 1997

rNAPc2 completes phase Ia testing with positive results

Sep. 25, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...